Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Interactive Brokers Group Inc. Class A Common Stock (IBKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Interactive Brokers Group Inc. Class A Common Stock — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Interactive Brokers Group Inc. Class A Common Stock trades at $83.87 (market cap $39.64B). The key difference: Interactive Brokers Group Inc. Class A Common Stock is far larger — about 4.7× Hinge Health Inc. Class A Common Stock's market cap, and Interactive Brokers Group Inc. Class A Common Stock pays a 0.4% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Interactive Brokers Group Inc. Class A Common Stock for 6 Days on average.
| HNGE | IBKR | |
|---|---|---|
Market Cap | $8.48B | $39.64B |
Volume | 879,799 | 2,886,805 |
Sector | Health | Financials |
52-Week High | $105.14 | $98.19 |
52-Week Low | $31.17 | $61.05 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $8.10B | $31.94B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Interactive Brokers (IBKR) trades at $87.49, down 0.46% on the day, with technical indicators showing a bearish bias despite neutral oscillators. The company demonstrates strong fundamentals with revenue growth from $10.22B in 2025 to $11.1B projected for 2026, and net income rising from $984M to $1.1B. Recent earnings beats and expansion into cryptocurrency staking highlight ongoing business development, though valuation multiples appear elevated with a P/E of 34.72.
The outlook remains cautiously optimistic given analyst consensus pointing to 21% upside to the $106.11 price target, balanced by near-term technical weakness and stretched valuations. Key risks include competitive pressures in fintech and market volatility impacting trading volumes, while institutional sentiment shows mixed but generally positive positioning with 47% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Interactive Brokers Group Inc. Class A Common Stock
Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.
Read more on IBKR →
